Screener
Teladoc Health TDOC Cash & Equivalents
Cash & Equivalents at other companies
Other financials
Where this comes from
Reported directly by Teladoc Health in its filing.
Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents.
The source filing: Teladoc Health’s 10-Q, filed July 30, 2026.
- Filed
- Jul 30, 2026, 9:54 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001477449-26-000038
| Line item | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|
| Net decrease in cash and cash equivalents | (5,508) | (624,777) |
| Effect of foreign currency exchange rate changes | (1,228) | 6,071 |
| Cash and cash equivalents at beginning of the period | 781,084 | 1,298,327 |
| Cash and cash equivalents at end of the period | $774,348 | $679,621 |
| Cash paid for income taxes, net | $3,222 | $5,661 |
| Interest paid | $6,255 | $8,661 |
| Supplemental disclosure of non-cash investing activities | ||
| Accruals related to Intangible assets, net and Property and equipment, net | $5,805 | $5,681 |
ITEM 1. Financial Statements
FAQ
- What is Teladoc Health's cash & equivalents?
- Teladoc Health (TDOC) reported cash & equivalents of $774.35M in Q2 2026.
- How has Teladoc Health's cash & equivalents changed year-over-year?
- Teladoc Health's cash & equivalents increased by 13.9% year-over-year, from $679.62M to $774.35M.
- What is the long-term trend for Teladoc Health's cash & equivalents?
- Over 5 years (2020 to 2025), Teladoc Health's cash & equivalents has grown at a 1.3% compound annual growth rate (CAGR), from $733.32M to $781.08M.
- What does cash & equivalents mean?
- Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.
Ask your AI about Teladoc Health's cash & equivalents.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude